![]() Tactical Therapeutics Tactical Therapeutics (TTI) is a clinical-stage company that develops a therapeutic for the orphan indication glioblastoma (GBM) and other refractory targets. | ![]() Curtana Pharmaceuticals Curtana Pharmaceuticals is a company specializing in therapies for brain cancer. | ![]() Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | ||
Founding Date | Founding Date N/A | Founding Date 2013 | Founding Date 1978 | Founding Date 2012 | Founding Date 2008 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations New York, US HQ | Locations Austin, US HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Shanghai, CN HQ | |
Employees | Employees N/A | Employees 7 | Employees 16,5612% increase | Employees 2,578 | Employees 5,669 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ¥466.5m (FY, 2025) | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) | Gross profit ¥2b (FY, 2025) | Gross profit ¥383.4b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ₹3.7b (FY, 2026) | Net income (¥1b) (FY, 2025) | Net income ¥67b (FY, 2025) |

Curtana Pharmaceuticals is a company specializing in therapies for brain cancer.
View company
Biocon is a company that develops and manufactures biopharmaceutical products.
View company
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View companyKyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company